Ectoparasiticides

Chewable tablets containing fluralaner for the treatment and prevention of flea and tick infestations in dogs. Bravecto is a chewable tablet for dogs containing fluralaner. It is for the treatment and prevention of flea and tick infestations in dogs, for the treatment of demodicosis caused by Demodex canis and for the treatment of sarcoptic mange (Sarcoptes scabiei var. canis) infestation in dogs. For uses, dosage, contra-indications and warnings please consult your veterinary practitioner or the Summary of Product Characteristics (SPC). Further information is available on request. Use medicines responsibly. Last up 12 weeks. The following tablet strengths are: Bravecto 112.5 mg chewable tablets for very small dogs (2-4.5 kg) Bravecto 250 mg chewable tablets for small dogs (>4.5-10 kg) Bravecto 500 mg chewable tablets for medium-sized dogs (>10-20 kg) Bravecto 1000 mg chewable tablets for large dogs (>20-40 kg) Bravecto 1400 mg chewable tablets for very large dogs (>40-56 kg).

Chewable tablets containing fluralaner for the treatment and prevention of flea and tick infestations in dogs. Bravecto is a chewable tablet for dogs containing fluralaner. It is for the treatment and prevention of flea and tick infestations in dogs, for the treatment of demodicosis caused by Demodex canis and for the treatment of sarcoptic mange (Sarcoptes scabiei var. canis) infestation in dogs. For uses, dosage, contra-indications and warnings please consult your veterinary practitioner or the Summary of Product Characteristics (SPC). Further information is available on request. Use medicines responsibly. Last up 12 weeks. The following tablet strengths are: Bravecto 112.5 mg chewable tablets for very small dogs (2-4.5 kg) Bravecto 250 mg chewable tablets for small dogs (>4.5-10 kg) Bravecto 500 mg chewable tablets for medium-sized dogs (>10-20 kg) Bravecto 1000 mg chewable tablets for large dogs (>20-40 kg) Bravecto 1400 mg chewable tablets for very large dogs (>40-56 kg).

Bravecto Plus spot-on solution for cats is a product for topical application containing fluralaner and moxidectin. It is for the treatment and prevention of flea and tick infestations and for the treatment of certain worms (roundworms (Toxocara cati), hookworms (Ancylostoma tubaeforme) and heartworm (Dirofilaria immitis) in cats. For cats with, or at risk from, mixed parasitic infestations by ticks or fleas and ear mites, gastrointestinal nematodes or heartworm. The veterinary medicinal product is exclusively indicated when used against ticks or fleas and one or more of the other target parasites is indicated at the same time. For the treatment of tick and flea infestations in cats providing immediate and persistent flea (Ctenocephalides felis) and tick (Ixodes ricinus) killing activity for 12 weeks. Fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance. The product can be used as part of a treatment strategy for flea allergy dermatitis (FAD). For the treatment of infestations with ear mites (Otodectes cynotis). For the treatment of infections with intestinal roundworm (4th stage larvae, immature adults and adults of Toxocara cati) and hookworm (4th stage larvae, immature adults and adults of Ancylostoma tubaeforme). When administered repeatedly at a 12-week interval, the product continuously prevents heartworm disease caused by Dirofilaria immitis. Packaging Quantities Bravecto 112.5 mg / 5.6mg spot-on solution for small cats (1.2 – 2.8 kg) Bravecto 250 mg / 12.5 mg spot-on solution for medium-sized cats (>2.8 – 6.25 kg) Bravecto 500 mg / 25 mg spot-on solution for large cats (>6.25 – 12.5 kg)Not all pack sizes may be marketed.

Bravecto Plus spot-on solution for cats is a product for topical application containing fluralaner and moxidectin. It is for the treatment and prevention of flea and tick infestations and for the treatment of certain worms (roundworms (Toxocara cati), hookworms (Ancylostoma tubaeforme) and heartworm (Dirofilaria immitis) in cats. For cats with, or at risk from, mixed parasitic infestations by ticks or fleas and ear mites, gastrointestinal nematodes or heartworm. The veterinary medicinal product is exclusively indicated when used against ticks or fleas and one or more of the other target parasites is indicated at the same time. For the treatment of tick and flea infestations in cats providing immediate and persistent flea (Ctenocephalides felis) and tick (Ixodes ricinus) killing activity for 12 weeks. Fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance. The product can be used as part of a treatment strategy for flea allergy dermatitis (FAD). For the treatment of infestations with ear mites (Otodectes cynotis). For the treatment of infections with intestinal roundworm (4th stage larvae, immature adults and adults of Toxocara cati) and hookworm (4th stage larvae, immature adults and adults of Ancylostoma tubaeforme). When administered repeatedly at a 12-week interval, the product continuously prevents heartworm disease caused by Dirofilaria immitis. Packaging Quantities Bravecto 112.5 mg / 5.6mg spot-on solution for small cats (1.2 – 2.8 kg) Bravecto 250 mg / 12.5 mg spot-on solution for medium-sized cats (>2.8 – 6.25 kg) Bravecto 500 mg / 25 mg spot-on solution for large cats (>6.25 – 12.5 kg)Not all pack sizes may be marketed.

Bravecto Plus spot-on solution for cats is a product for topical application containing fluralaner and moxidectin. It is for the treatment and prevention of flea and tick infestations and for the treatment of certain worms (roundworms (Toxocara cati), hookworms (Ancylostoma tubaeforme) and heartworm (Dirofilaria immitis) in cats. For cats with, or at risk from, mixed parasitic infestations by ticks or fleas and ear mites, gastrointestinal nematodes or heartworm. The veterinary medicinal product is exclusively indicated when used against ticks or fleas and one or more of the other target parasites is indicated at the same time. For the treatment of tick and flea infestations in cats providing immediate and persistent flea (Ctenocephalides felis) and tick (Ixodes ricinus) killing activity for 12 weeks. Fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance. The product can be used as part of a treatment strategy for flea allergy dermatitis (FAD). For the treatment of infestations with ear mites (Otodectes cynotis). For the treatment of infections with intestinal roundworm (4th stage larvae, immature adults and adults of Toxocara cati) and hookworm (4th stage larvae, immature adults and adults of Ancylostoma tubaeforme). When administered repeatedly at a 12-week interval, the product continuously prevents heartworm disease caused by Dirofilaria immitis. Packaging Quantities Bravecto 112.5 mg / 5.6mg spot-on solution for small cats (1.2 – 2.8 kg) Bravecto 250 mg / 12.5 mg spot-on solution for medium-sized cats (>2.8 – 6.25 kg) Bravecto 500 mg / 25 mg spot-on solution for large cats (>6.25 – 12.5 kg)Not all pack sizes may be marketed.

Bravecto Spot-On Solution is an ectoparasiticide treatment for cats that contains the active ingredient fluralaner. It is a flea and tick treatment of the isoxazoline class for cats with a duration of effect of 12 weeks. Bravecto contributes towards the control of the environmental flea populations due to the rapid onset of action and long lasting efficacy against adult fleas on the animal and the absence of viable egg production. Indications for use: This veterinary medicinal product is a systemic insecticide and acaricide that provides: Immediate and persistent flea (Ctenocephalides felis) and tick (Ixodes ricinus) killing activity for 12 weeks. Used as part of a treatment strategy for the control of flea allergy dermatitis (FAD). Bravecto Spot-on for cats can be used from 9 weeks of age and 1.2 kg in bodyweight.

Bravecto Spot-On Solution is an ectoparasiticide systemic treatment for dogs that contains the active ingredient fluralaner. It is a flea and tick treatment of the isoxazoline class for dogs with a duration of effect of 12 weeks. Bravecto contributes towards the control of the environmental flea populations due to the rapid onset of action and long lasting efficacy against adult fleas on the animal and the absence of viable egg production. Indications for use: This veterinary medicinal product is a systemic insecticide and acaricide that provides: Immediate and persistent flea (Ctenocephalides felis and Ctenocephalides canis) killing activity for 12 weeks. Immediate and persistent tick (Ixodes ricinus, Rhipicephalus sanguineus and Dermacentor reticulatus) killing activity for 12 weeks. Used as part of a treatment strategy for the control of flea allergy dermatitis (FAD). For the treatment of demodicosis caused by Demodex canis. For the treatment of sarcoptic mange (Sarcoptes scabei var. canis) infestation. Bravecto Spot-on for dogs can be used from 8 weeks of age and 2 kg in bodyweight.

Bravecto Spot-On Solution is an ectoparasiticide systemic treatment for dogs that contains the active ingredient fluralaner. It is a flea and tick treatment of the isoxazoline class for dogs with a duration of effect of 12 weeks. Bravecto contributes towards the control of the environmental flea populations due to the rapid onset of action and long lasting efficacy against adult fleas on the animal and the absence of viable egg production. Indications for use: This veterinary medicinal product is a systemic insecticide and acaricide that provides: Immediate and persistent flea (Ctenocephalides felis and Ctenocephalides canis) killing activity for 12 weeks. Immediate and persistent tick (Ixodes ricinus, Rhipicephalus sanguineus and Dermacentor reticulatus) killing activity for 12 weeks. Used as part of a treatment strategy for the control of flea allergy dermatitis (FAD). For the treatment of demodicosis caused by Demodex canis. For the treatment of sarcoptic mange (Sarcoptes scabei var. canis) infestation. Bravecto Spot-on for dogs can be used from 8 weeks of age and 2 kg in bodyweight.

Bravecto Spot-On Solution is an ectoparasiticide systemic treatment for dogs that contains the active ingredient fluralaner. It is a flea and tick treatment of the isoxazoline class for dogs with a duration of effect of 12 weeks. Bravecto contributes towards the control of the environmental flea populations due to the rapid onset of action and long lasting efficacy against adult fleas on the animal and the absence of viable egg production. Indications for use: This veterinary medicinal product is a systemic insecticide and acaricide that provides: Immediate and persistent flea (Ctenocephalides felis and Ctenocephalides canis) killing activity for 12 weeks. Immediate and persistent tick (Ixodes ricinus, Rhipicephalus sanguineus and Dermacentor reticulatus) killing activity for 12 weeks. Used as part of a treatment strategy for the control of flea allergy dermatitis (FAD). For the treatment of demodicosis caused by Demodex canis. For the treatment of sarcoptic mange (Sarcoptes scabei var. canis) infestation. Bravecto Spot-on for dogs can be used from 8 weeks of age and 2 kg in bodyweight.

Bravecto Spot-On Solution is an ectoparasiticide systemic treatment for dogs that contains the active ingredient fluralaner. It is a flea and tick treatment of the isoxazoline class for dogs with a duration of effect of 12 weeks. Bravecto contributes towards the control of the environmental flea populations due to the rapid onset of action and long lasting efficacy against adult fleas on the animal and the absence of viable egg production. Indications for use: This veterinary medicinal product is a systemic insecticide and acaricide that provides: Immediate and persistent flea (Ctenocephalides felis and Ctenocephalides canis) killing activity for 12 weeks. Immediate and persistent tick (Ixodes ricinus, Rhipicephalus sanguineus and Dermacentor reticulatus) killing activity for 12 weeks. Used as part of a treatment strategy for the control of flea allergy dermatitis (FAD). For the treatment of demodicosis caused by Demodex canis. For the treatment of sarcoptic mange (Sarcoptes scabei var. canis) infestation. Bravecto Spot-on for dogs can be used from 8 weeks of age and 2 kg in bodyweight.

Bravecto Spot-On Solution is an ectoparasiticide systemic treatment for dogs that contains the active ingredient fluralaner. It is a flea and tick treatment of the isoxazoline class for dogs with a duration of effect of 12 weeks. Bravecto contributes towards the control of the environmental flea populations due to the rapid onset of action and long lasting efficacy against adult fleas on the animal and the absence of viable egg production. Indications for use: This veterinary medicinal product is a systemic insecticide and acaricide that provides: Immediate and persistent flea (Ctenocephalides felis and Ctenocephalides canis) killing activity for 12 weeks. Immediate and persistent tick (Ixodes ricinus, Rhipicephalus sanguineus and Dermacentor reticulatus) killing activity for 12 weeks. Used as part of a treatment strategy for the control of flea allergy dermatitis (FAD). For the treatment of demodicosis caused by Demodex canis. For the treatment of sarcoptic mange (Sarcoptes scabei var. canis) infestation. Bravecto Spot-on for dogs can be used from 8 weeks of age and 2 kg in bodyweight.

Bravecto Spot-On Solution is an ectoparasiticide systemic treatment for dogs that contains the active ingredient fluralaner. It is a flea and tick treatment of the isoxazoline class for dogs with a duration of effect of 12 weeks. Bravecto contributes towards the control of the environmental flea populations due to the rapid onset of action and long lasting efficacy against adult fleas on the animal and the absence of viable egg production. Indications for use: This veterinary medicinal product is a systemic insecticide and acaricide that provides: Immediate and persistent flea (Ctenocephalides felis and Ctenocephalides canis) killing activity for 12 weeks. Immediate and persistent tick (Ixodes ricinus, Rhipicephalus sanguineus and Dermacentor reticulatus) killing activity for 12 weeks. Used as part of a treatment strategy for the control of flea allergy dermatitis (FAD). For the treatment of demodicosis caused by Demodex canis. For the treatment of sarcoptic mange (Sarcoptes scabei var. canis) infestation. Bravecto Spot-on for dogs can be used from 8 weeks of age and 2 kg in bodyweight.